首页 > 最新文献

Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry最新文献

英文 中文
Effect of Ethanol on Platelet Biology 乙醇对血小板生物学的影响
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-11-16 DOI: 10.1134/S1990750822040023
M. I. Airapetov, S. O. Eresko, E. R. Bychkov, A. A. Lebedev, P. D. Shabanov

In recent years, there has been interest in the study of platelets, the functions of which, as it turned out, are not limited to their involvement in the mechanism of blood coagulation. Many works are devoted to the study of the functional state of platelets under conditions of acute and chronic alcohol exposure. The results of such studies can be useful in the development of new markers of the degree of alcohol intoxication of the body for the subsequent choice of a method for drug correction of disorders caused by acute or chronic alcohol effects. The review summarizes the results of studies on the effect of ethanol on the platelet biogenesis, abundance, morphology, and biochemistry. An analysis of studies performed both in vitro and in experimental animals in vivo, as well as the results of clinical observations, is presented.

近年来,人们对血小板的研究产生了兴趣,血小板的功能不仅限于参与血液凝固机制。许多工作致力于研究急性和慢性酒精暴露条件下血小板的功能状态。这些研究的结果可用于开发身体酒精中毒程度的新标记物,以便随后选择一种方法对急性或慢性酒精作用引起的紊乱进行药物矫正。本文综述了近年来乙醇对血小板生物发生、丰度、形态及生化等方面的影响。对在体外和实验动物体内进行的研究以及临床观察结果进行了分析。
{"title":"Effect of Ethanol on Platelet Biology","authors":"M. I. Airapetov,&nbsp;S. O. Eresko,&nbsp;E. R. Bychkov,&nbsp;A. A. Lebedev,&nbsp;P. D. Shabanov","doi":"10.1134/S1990750822040023","DOIUrl":"10.1134/S1990750822040023","url":null,"abstract":"<p>In recent years, there has been interest in the study of platelets, the functions of which, as it turned out, are not limited to their involvement in the mechanism of blood coagulation. Many works are devoted to the study of the functional state of platelets under conditions of acute and chronic alcohol exposure. The results of such studies can be useful in the development of new markers of the degree of alcohol intoxication of the body for the subsequent choice of a method for drug correction of disorders caused by acute or chronic alcohol effects. The review summarizes the results of studies on the effect of ethanol on the platelet biogenesis, abundance, morphology, and biochemistry. An analysis of studies performed both in vitro and in experimental animals in vivo, as well as the results of clinical observations, is presented.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 4","pages":"305 - 317"},"PeriodicalIF":0.6,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4658770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-Ischemic and Antioxidant Activity of the Pharmacological Agonist of Galanin Receptor GalR2 and Carnosine in In Vitro and In Vivo Model Systems 甘丙氨酸受体GalR2和肌肽在体外和体内模型系统中的抗缺血和抗氧化活性
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-11-16 DOI: 10.1134/S1990750822040072
L. I. Serebryakova, I. M. Studneva, O. M. Veselova, I. V. Dobrokhotov, G. G. Konovalova, A. A. Timoshin, A. A. Abramov, D. V. Avdeev, M. V. Sidorova, V. Z. Lankin, O. I. Pisarenko

Antioxidant and anti-ischemic properties of the pharmacological agonist of galanin receptor GalR2 WTLNSAGYLLGPβAH (Gal) and its C-terminal fragment, dipeptide carnosine (βAH), have been studied in the model of regional ischemia and reperfusion of a rat heart in vivo in the dose range of 0.5–5.0 mg/kg and Сu2+-induced free radical oxidation of low-density lipoproteins (LDLs) of human plasma in vitro for peptide concentrations of 0.01 mM and 0.1 mM. Gal was obtained by automatic solid phase synthesis using the Fmoc methodology; its structure was characterized by 1H-NMR spectroscopy and MALDI-TOF mass spectrometry. Intravenous administration of the optimal dose of Gal (1 mg/kg) to rats after ischemia was more effective than carnosine at reducing the myocardial infarct size and the activity of creatine kinase-MB and lactate dehydrogenase in blood plasma at the end of reperfusion. It also improved the metabolic state of the reperfused myocardium and decreased the formation of peroxidation products during reperfusion. Gal reduced more effectively the formation of adducts of hydroxyl radicals in the interstitium of the area at risk (AAR) of the rat heart than carnosine. Carnosine at a dose of 1 mg/kg more effectively increased the activity of catalase and glutathione peroxidase in the AAR by the end of reperfusion compared to Gal. In the model of Cu2+-initiated oxidation of human plasma LDLs 0.1 mM, carnosine demonstrated a significantly more pronounced reduction in the formation of lipid radicals compared to Gal. The results show that Gal can be viewed as a promising agent that reduces myocardial injury during reperfusion and oxidative stress.

甘丙肽受体GalR2药理激动剂WTLNSAGYLLGPβAH (Gal)及其c端片段二肽肌肽(βAH)的抗氧化和抗缺血特性在大鼠心脏局部缺血再灌注模型中研究了0.5-5.0 mg/kg和Сu2+在体外诱导人血浆低密度脂蛋白(ldl)的自由基氧化,肽浓度分别为0.01 mM和0.1 mM。Gal采用Fmoc方法自动固相合成;通过1H-NMR和MALDI-TOF质谱对其结构进行了表征。大鼠缺血后静脉给予最佳剂量的Gal (1 mg/kg)比肌肽更有效地减少心肌梗死面积和再灌注结束时血浆肌酸激酶- mb和乳酸脱氢酶的活性。改善再灌注心肌的代谢状态,减少再灌注时过氧化产物的形成。Gal比肌肽更有效地减少了大鼠心脏危险区域(AAR)间质羟基自由基加合物的形成。在再灌注结束时,与Gal相比,1 mg/kg剂量的肌肽更有效地增加了AAR中过氧化氢酶和谷胱甘肽过氧化物酶的活性。在Cu2+引发的人体血浆ldl 0.1 mM氧化模型中,肌肽比Gal更明显地减少了脂质自由基的形成。结果表明,Gal可以被视为一种有希望减少再灌注和氧化应激时心肌损伤的药物。
{"title":"Anti-Ischemic and Antioxidant Activity of the Pharmacological Agonist of Galanin Receptor GalR2 and Carnosine in In Vitro and In Vivo Model Systems","authors":"L. I. Serebryakova,&nbsp;I. M. Studneva,&nbsp;O. M. Veselova,&nbsp;I. V. Dobrokhotov,&nbsp;G. G. Konovalova,&nbsp;A. A. Timoshin,&nbsp;A. A. Abramov,&nbsp;D. V. Avdeev,&nbsp;M. V. Sidorova,&nbsp;V. Z. Lankin,&nbsp;O. I. Pisarenko","doi":"10.1134/S1990750822040072","DOIUrl":"10.1134/S1990750822040072","url":null,"abstract":"<p>Antioxidant and anti-ischemic properties of the pharmacological agonist of galanin receptor GalR2 WTLNSAGYLLGPβAH (Gal) and its C-terminal fragment, dipeptide carnosine (βAH), have been studied in the model of regional ischemia and reperfusion of a rat heart in vivo in the dose range of 0.5–5.0 mg/kg and Сu<sup>2+</sup>-induced free radical oxidation of low-density lipoproteins (LDLs) of human plasma in vitro for peptide concentrations of 0.01 mM and 0.1 mM. Gal was obtained by automatic solid phase synthesis using the Fmoc methodology; its structure was characterized by <sup>1</sup>H-NMR spectroscopy and MALDI-TOF mass spectrometry. Intravenous administration of the optimal dose of Gal (1 mg/kg) to rats after ischemia was more effective than carnosine at reducing the myocardial infarct size and the activity of creatine kinase-MB and lactate dehydrogenase in blood plasma at the end of reperfusion. It also improved the metabolic state of the reperfused myocardium and decreased the formation of peroxidation products during reperfusion. Gal reduced more effectively the formation of adducts of hydroxyl radicals in the interstitium of the area at risk (AAR) of the rat heart than carnosine. Carnosine at a dose of 1 mg/kg more effectively increased the activity of catalase and glutathione peroxidase in the AAR by the end of reperfusion compared to Gal. In the model of Cu<sup>2+</sup>-initiated oxidation of human plasma LDLs 0.1 mM, carnosine demonstrated a significantly more pronounced reduction in the formation of lipid radicals compared to Gal. The results show that Gal can be viewed as a promising agent that reduces myocardial injury during reperfusion and oxidative stress.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 4","pages":"340 - 352"},"PeriodicalIF":0.6,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4658419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contents of BDNF, miR-30a-5p AND miR-122 during Alcohol Withdrawal Syndrome 酒精戒断综合征期间BDNF、miR-30a-5p和miR-122的含量
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-11-16 DOI: 10.1134/S1990750822040060
D. I. Peregud, A. I. Korolkov, V. Y. Baronets, A. S. Lobacheva, M. L. Arkus, S. A. Igumnov, S. V. Pirozhkov, N. N. Terebilina

Some brain-derived neurotrophic factor (BDNF)-targeted miRNAs such as miR-30a-5p may be associated with alcohol addiction; however, their relationship with alcohol withdrawal syndrome (AWS) is not described. We aimed to measure serum BDNF concentration and relative content of miR-30a-5p over the course of alcohol abstinence and compare results with the clinics of AWS. Apart from that, we studied the serum relative content of miR-122, a miRNA that does not target BDNF but is associated with alcohol use disorder. Serum BDNF concentration increases over the course of alcohol abstinence. In contrast, the relative content of miR-122, but not miR-30a-5p, decreased. Moreover, miR-122 (but not miR-30a-5p) negatively correlated with serum BDNF concentrations in the course of AWS. The relative content of miR-122 negatively correlated with depression and anxiety levels on day 8 of abstinence. According to multiple regression analysis, the severity of craving for alcohol and cognitive disturbances may be predictors of serum BDNF concentration on day 21 of abstinence, and vice versa. Thus, serum BDNF concentration and relative content of miR-122 are associated with some aspects of AWS clinical manifestations and may dynamically reflect AWS severity.

一些脑源性神经营养因子(BDNF)靶向mirna如miR-30a-5p可能与酒精成瘾有关;然而,他们与酒精戒断综合征(AWS)的关系没有被描述。我们的目的是在戒酒过程中测量血清BDNF浓度和miR-30a-5p的相对含量,并将结果与AWS的临床结果进行比较。除此之外,我们研究了miR-122的血清相对含量,miR-122是一种不靶向BDNF但与酒精使用障碍相关的miRNA。血清BDNF浓度在戒酒过程中升高。相比之下,miR-122的相对含量下降,而miR-30a-5p的相对含量没有下降。此外,在AWS过程中,miR-122(而非miR-30a-5p)与血清BDNF浓度呈负相关。禁欲第8天miR-122的相对含量与抑郁、焦虑水平呈负相关。多元回归分析表明,嗜酒严重程度和认知障碍可能是戒断第21天血清BDNF浓度的预测因子,反之亦然。因此,血清BDNF浓度和miR-122的相对含量与AWS临床表现的某些方面相关,并可能动态反映AWS的严重程度。
{"title":"Contents of BDNF, miR-30a-5p AND miR-122 during Alcohol Withdrawal Syndrome","authors":"D. I. Peregud,&nbsp;A. I. Korolkov,&nbsp;V. Y. Baronets,&nbsp;A. S. Lobacheva,&nbsp;M. L. Arkus,&nbsp;S. A. Igumnov,&nbsp;S. V. Pirozhkov,&nbsp;N. N. Terebilina","doi":"10.1134/S1990750822040060","DOIUrl":"10.1134/S1990750822040060","url":null,"abstract":"<p>Some brain-derived neurotrophic factor (BDNF)-targeted miRNAs such as miR-30a-5p may be associated with alcohol addiction; however, their relationship with alcohol withdrawal syndrome (AWS) is not described. We aimed to measure serum BDNF concentration and relative content of miR-30a-5p over the course of alcohol abstinence and compare results with the clinics of AWS. Apart from that, we studied the serum relative content of miR-122, a miRNA that does not target BDNF but is associated with alcohol use disorder. Serum BDNF concentration increases over the course of alcohol abstinence. In contrast, the relative content of miR-122, but not miR-30a-5p, decreased. Moreover, miR-122 (but not miR-30a-5p) negatively correlated with serum BDNF concentrations in the course of AWS. The relative content of miR-122 negatively correlated with depression and anxiety levels on day 8 of abstinence. According to multiple regression analysis, the severity of craving for alcohol and cognitive disturbances may be predictors of serum BDNF concentration on day 21 of abstinence, and vice versa. Thus, serum BDNF concentration and relative content of miR-122 are associated with some aspects of AWS clinical manifestations and may dynamically reflect AWS severity.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 4","pages":"353 - 363"},"PeriodicalIF":0.6,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4658420","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection SARS-CoV-2感染中蛋白水解及α - 1蛋白酶抑制剂缺乏
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-11-16 DOI: 10.1134/S1990750822040035
O. E. Akbasheva, L. V. Spirina, D. A. Dyakov, N. V. Masunova

The SARS-CoV-2 pandemic had stimulated the emergence of numerous publications on the α1-proteinase inhibitor (α1-PI, α1-antitrypsin), especially when it was found that the regions of high mortality corresponded to the regions with deficient α1-PI alleles. By analogy with the data obtained in the last century, when the first cause of the genetic deficiency of α1-antitrypsin leading to elastase activation in pulmonary emphysema was proven, it can be supposed that proteolysis hyperactivation in COVID-19 may be associated with the impaired functions of α1-PI. The purpose of this review was to systematize the scientific data and critical directions for translational studies on the role of α1-PI in SARS-CoV-2-induced proteolysis hyperactivation as a diagnostic marker and a therapeutic target. This review describes the proteinase-dependent stages of viral infection: the reception and penetration of the virus into a cell and the imbalance of the plasma aldosterone–angiotensin–renin, kinin, and blood clotting systems. The role of ACE2, TMPRSS, ADAM17, furin, cathepsins, trypsin- and elastase-like serine proteinases in the virus tropism, the activation of proteolytic cascades in blood, and the COVID-19-dependent complications is considered. The scientific reports on α1-PI involvement in the SARS-CoV-2-induced inflammation, the relationship with the severity of infection and comorbidities were analyzed. Particular attention is paid to the acquired α1-PI deficiency in assessing the state of patients with proteolysis overactivation and chronic non-inflammatory diseases, which are accompanied by the risk factors for comorbidity progression and the long-term consequences of COVID-19. Essential data on the search and application of protease inhibitor drugs in the therapy for bronchopulmonary and cardiovascular pathologies were analyzed. The evidence of antiviral, anti-inflammatory, anticoagulant, and anti-apoptotic effects of α1-PI, as well as the prominent data and prospects for its application as a targeted drug in the SARS-CoV-2 acquired pneumonia and related disorders, are presented.

SARS-CoV-2大流行刺激了大量关于α1-蛋白酶抑制剂(α1-PI, α1-抗胰蛋白酶)的出版物的出现,特别是当发现高死亡率区域与α1-PI等位基因缺陷区域相对应时。类比上个世纪的数据,当α1-抗胰蛋白酶基因缺陷导致肺气肿弹性酶激活的第一个原因被证实时,可以推测COVID-19蛋白水解过度激活可能与α1-PI功能受损有关。本文综述了α1-PI在sars - cov -2诱导的蛋白水解过度激活中作为诊断标志物和治疗靶点的作用的科学数据和翻译研究的关键方向。这篇综述描述了病毒感染的蛋白酶依赖阶段:病毒的接受和渗透到细胞中,血浆醛固酮-血管紧张素-肾素,激肽和血液凝固系统的失衡。考虑ACE2、TMPRSS、ADAM17、furin、组织蛋白酶、胰蛋白酶和弹性酶样丝氨酸蛋白酶在病毒趋向性、血液蛋白水解级联激活以及covid -19依赖性并发症中的作用。分析α1-PI参与sars - cov -2诱导炎症的科学报道,并与感染严重程度及合并症的关系。在评估蛋白水解过度激活和慢性非炎症性疾病患者的状态时,需要特别关注获得性α1-PI缺乏,这是伴随合并症进展和COVID-19长期后果的危险因素。分析了蛋白酶抑制剂药物在支气管肺和心血管疾病治疗中的研究和应用的基本资料。本文综述了α1-PI在抗病毒、抗炎、抗凝、抗细胞凋亡等方面的作用,以及α1-PI作为靶向药物在SARS-CoV-2获得性肺炎及相关疾病中的应用。
{"title":"Proteolysis and Deficiency of α1-Proteinase Inhibitor in SARS-CoV-2 Infection","authors":"O. E. Akbasheva,&nbsp;L. V. Spirina,&nbsp;D. A. Dyakov,&nbsp;N. V. Masunova","doi":"10.1134/S1990750822040035","DOIUrl":"10.1134/S1990750822040035","url":null,"abstract":"<div><p>The SARS-CoV-2 pandemic had stimulated the emergence of numerous publications on the α<sub>1</sub>-proteinase inhibitor (α<sub>1</sub>-PI, α<sub>1</sub>-antitrypsin), especially when it was found that the regions of high mortality corresponded to the regions with deficient α<sub>1</sub>-PI alleles. By analogy with the data obtained in the last century, when the first cause of the genetic deficiency of α<sub>1</sub>-antitrypsin leading to elastase activation in pulmonary emphysema was proven, it can be supposed that proteolysis hyperactivation in COVID-19 may be associated with the impaired functions of α<sub>1</sub>-PI. The purpose of this review was to systematize the scientific data and critical directions for translational studies on the role of α<sub>1</sub>-PI in SARS-CoV-2-induced proteolysis hyperactivation as a diagnostic marker and a therapeutic target. This review describes the proteinase-dependent stages of viral infection: the reception and penetration of the virus into a cell and the imbalance of the plasma aldosterone–angiotensin–renin, kinin, and blood clotting systems. The role of ACE2, TMPRSS, ADAM17, furin, cathepsins, trypsin- and elastase-like serine proteinases in the virus tropism, the activation of proteolytic cascades in blood, and the COVID-19-dependent complications is considered. The scientific reports on α<sub>1</sub>-PI involvement in the SARS-CoV-2-induced inflammation, the relationship with the severity of infection and comorbidities were analyzed. Particular attention is paid to the acquired α<sub>1</sub>-PI deficiency in assessing the state of patients with proteolysis overactivation and chronic non-inflammatory diseases, which are accompanied by the risk factors for comorbidity progression and the long-term consequences of COVID-19. Essential data on the search and application of protease inhibitor drugs in the therapy for bronchopulmonary and cardiovascular pathologies were analyzed. The evidence of antiviral, anti-inflammatory, anticoagulant, and anti-apoptotic effects of α<sub>1</sub>-PI, as well as the prominent data and prospects for its application as a targeted drug in the SARS-CoV-2 acquired pneumonia and related disorders, are presented.</p></div>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 4","pages":"271 - 291"},"PeriodicalIF":0.6,"publicationDate":"2022-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1134/S1990750822040035.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4661507","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Mechanisms of Development of Side Effects and Drug Resistance to Asparaginase and Ways to Overcome Them 天冬酰胺酶毒副反应和耐药性的发生机制及克服方法
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-08-15 DOI: 10.1134/S1990750822030027
S. S. Alexandrova, Y. A. Gladilina, M. V. Pokrovskaya, N. N. Sokolov, D. D. Zhdanov

Asparaginase is one of the most important chemotherapeutic agents against acute lymphoblastic leukemia, the most common form of blood cancer. To date, both asparaginases from E. coli and Dickeya dadantii (formerly known as Erwinia chrysanthemi), used in hematology, induce chemoresistance in cancer cells and side effects in the form of hypersensitivity of immune reactions. Leukemic cells may be resistant to asparaginase due to the increased activity of asparagine synthetase and other mechanisms associated with resistance to asparaginase. Therefore, the search for new sources of L-asparaginases with improved pharmacological properties remains a promising and prospective study. This article discusses the mechanisms of development of resistance and drug resistance to L-asparaginase, as well as possible ways to overcome them.

天冬酰胺酶是治疗急性淋巴细胞白血病(最常见的血癌)最重要的化疗药物之一。迄今为止,在血液学中使用的大肠杆菌和菊花双胞杆菌(以前称为菊花Erwinia)的两种天冬酰胺酶都能诱导癌细胞产生化学耐药性,并以免疫反应过敏的形式产生副作用。白血病细胞可能由于天冬酰胺合成酶活性的增加以及与天冬酰胺酶抗性相关的其他机制而对天冬酰胺酶产生抗性。因此,寻找具有改进药理特性的l -天冬酰胺酶的新来源仍然是一项有前景的研究。本文讨论了l -天冬酰胺酶耐药和耐药的发生机制,以及克服它们的可能途径。
{"title":"Mechanisms of Development of Side Effects and Drug Resistance to Asparaginase and Ways to Overcome Them","authors":"S. S. Alexandrova,&nbsp;Y. A. Gladilina,&nbsp;M. V. Pokrovskaya,&nbsp;N. N. Sokolov,&nbsp;D. D. Zhdanov","doi":"10.1134/S1990750822030027","DOIUrl":"10.1134/S1990750822030027","url":null,"abstract":"<p>Asparaginase is one of the most important chemotherapeutic agents against acute lymphoblastic leukemia, the most common form of blood cancer. To date, both asparaginases from <i>E. coli</i> and <i>Dickeya dadantii</i> (formerly known as <i>Erwinia chrysanthemi</i>), used in hematology, induce chemoresistance in cancer cells and side effects in the form of hypersensitivity of immune reactions. Leukemic cells may be resistant to asparaginase due to the increased activity of asparagine synthetase and other mechanisms associated with resistance to asparaginase. Therefore, the search for new sources of L-asparaginases with improved pharmacological properties remains a promising and prospective study. This article discusses the mechanisms of development of resistance and drug resistance to L-asparaginase, as well as possible ways to overcome them.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 3","pages":"175 - 186"},"PeriodicalIF":0.6,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4600780","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Clinical and Diagnostic Significance of Sialic Acids Determination in Biological Material 生物材料中唾液酸测定的临床和诊断意义
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-08-15 DOI: 10.1134/S199075082203012X
I. V. Volkhina, E. G. Butolin

Sialic acids (SA) are neuraminic acid derivatives, located at the terminal position in the chains of monosaccharide residues of various glycoconjugates. SA play a dual role: they either mask recognition sites, or, on the contrary, represent biological targets that can be recognized by receptor proteins and serve as ligands. The desialylation/sialylation processes can be considered as a dynamic modification regulated by sialyltransferases and sialidases in response to external or internal stimuli. This review describes the structural and functional diversity and the potential use of SA fractions as biomarkers for various pathological conditions. Almost any extreme impact on the body and inflammatory processes are accompanied by an increase in the level of both total and free SA in the blood and tissues. Possible reasons for the increase of sialoglycoconjugate metabolism indicators in biological material include: (i) activation of the hepatocyte synthesis and secretion of various acute-phase proteins, many of which are sialoglycoproteins, (ii) impaired membrane integrity and destruction of body cells, (iii) high activity of sialidases (neurominidases) and sialyltransferases. Most acute and chronic liver diseases are characterized by the decrease in the total level of SA in the blood serum (because many plasma proteins are synthesized and glycosylated in hepatocytes). Aberrant sialylation results in changes of sialoglycoconjugate structure, its ability to perform biological functions and sialoglycoconjugate half-life. Glycosylation is the most common post-translational modification of proteins in the virus, which not only promotes the formation of specific conformation of viral proteins, but also modulates their interaction with receptors and affects host cell recognition, viral replication and infectivity. Serum total SA concentration increases in some benign and inflammatory conditions, which indicates a lack of specificity and limits their use for early detection and screening of neoplastic diseases. Clinical and diagnostic value of determining the sialoglycoconjugate metabolic indicators, including changes in the content of both SA fractions and specific proteins in various biological fluids and tissues, consists in establishing the causes and mechanisms of biochemical changes in the body in certain diseases. In combination with the measurement of existing markers, they can be used to improve diagnosis, staging and monitoring of therapeutic response in some pathological conditions where the need for specificity is less than for specific diagnostics.

唾液酸(SA)是神经氨酸衍生物,位于各种糖缀合物的单糖残基链的末端位置。SA起着双重作用:它们要么掩盖识别位点,要么相反,代表可以被受体蛋白识别并作为配体的生物学靶点。脱硅醛化/唾液酰化过程可以被认为是一种由唾液酰转移酶和唾液酰化酶响应外部或内部刺激而调节的动态修饰。本文综述了SA组分的结构和功能多样性以及作为各种病理条件的生物标志物的潜在用途。几乎任何对身体和炎症过程的极端影响都伴随着血液和组织中总SA和游离SA水平的增加。生物材料中唾液糖缀合物代谢指标增加的可能原因包括:(1)激活肝细胞各种急性期蛋白的合成和分泌,其中许多是唾液糖蛋白;(2)膜完整性受损和体细胞破坏;(3)唾液酸酶(神经氨酸酶)和唾液酸转移酶的高活性。大多数急慢性肝病的特点是血清中SA总水平降低(因为许多血浆蛋白在肝细胞中合成并糖基化)。异常的唾液酰化会导致唾液糖缀合物结构、生物学功能和唾液糖缀合物半衰期的改变。糖基化是病毒中最常见的蛋白质翻译后修饰,不仅促进病毒蛋白特异性构象的形成,而且调节其与受体的相互作用,影响宿主细胞识别、病毒复制和传染性。血清总SA浓度在一些良性和炎症性疾病中升高,这表明缺乏特异性,限制了它们在早期发现和筛查肿瘤疾病中的应用。唾液糖缀合代谢指标的测定,包括各种生物体液和组织中SA组分和特定蛋白质含量的变化,其临床和诊断价值在于确定某些疾病中机体生化变化的原因和机制。与现有标记物的测量相结合,它们可用于改善某些病理条件下的诊断、分期和治疗反应监测,这些病理条件对特异性的需求低于特异性诊断。
{"title":"Clinical and Diagnostic Significance of Sialic Acids Determination in Biological Material","authors":"I. V. Volkhina,&nbsp;E. G. Butolin","doi":"10.1134/S199075082203012X","DOIUrl":"10.1134/S199075082203012X","url":null,"abstract":"<p>Sialic acids (SA) are neuraminic acid derivatives, located at the terminal position in the chains of monosaccharide residues of various glycoconjugates. SA play a dual role: they either mask recognition sites, or, on the contrary, represent biological targets that can be recognized by receptor proteins and serve as ligands. The desialylation/sialylation processes can be considered as a dynamic modification regulated by sialyltransferases and sialidases in response to external or internal stimuli. This review describes the structural and functional diversity and the potential use of SA fractions as biomarkers for various pathological conditions. Almost any extreme impact on the body and inflammatory processes are accompanied by an increase in the level of both total and free SA in the blood and tissues. Possible reasons for the increase of sialoglycoconjugate metabolism indicators in biological material include: (i) activation of the hepatocyte synthesis and secretion of various acute-phase proteins, many of which are sialoglycoproteins, (ii) impaired membrane integrity and destruction of body cells, (iii) high activity of sialidases (neurominidases) and sialyltransferases. Most acute and chronic liver diseases are characterized by the decrease in the total level of SA in the blood serum (because many plasma proteins are synthesized and glycosylated in hepatocytes). Aberrant sialylation results in changes of sialoglycoconjugate structure, its ability to perform biological functions and sialoglycoconjugate half-life. Glycosylation is the most common post-translational modification of proteins in the virus, which not only promotes the formation of specific conformation of viral proteins, but also modulates their interaction with receptors and affects host cell recognition, viral replication and infectivity. Serum total SA concentration increases in some benign and inflammatory conditions, which indicates a lack of specificity and limits their use for early detection and screening of neoplastic diseases. Clinical and diagnostic value of determining the sialoglycoconjugate metabolic indicators, including changes in the content of both SA fractions and specific proteins in various biological fluids and tissues, consists in establishing the causes and mechanisms of biochemical changes in the body in certain diseases. In combination with the measurement of existing markers, they can be used to improve diagnosis, staging and monitoring of therapeutic response in some pathological conditions where the need for specificity is less than for specific diagnostics.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 3","pages":"165 - 174"},"PeriodicalIF":0.6,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1134/S199075082203012X.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4599406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Adrenodoxins and Their Role in the Cytochrome P450 Systems 肾上腺素及其在细胞色素P450系统中的作用
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-08-15 DOI: 10.1134/S1990750822030106
V. V. Shumyantseva, T. V. Bulko, O. V. Gnedenko, E. O. Yablokov, S. A. Usanov, A. S. Ivanov

Abstract

The role of partner proteins in the formation of functional complexes in cytochrome P450 systems was investigated by means of the optical biosensor technique, used to determine kinetic constants and equilibrium dissociation constants of complexes of cytochrome CYP11A1 (P450scc) with wild-type adrenodoxin (Adx WT) and mutant forms of adrenodoxin R106D and D109R. Wild-type adrenodoxin (Kd = (1.23 ± 0.09) × 10–6 M) and mutant D109R (Kd = (2.37 ± 0.09) × 10–8 M) formed complexes with cytochrome P450scc. In the case of the R106D mutant, no complex formation was detected. The possibility of participation of adrenodoxins and their mutant variants in the process of electron transfer as electron donors in mitochondrial cytochrome P450 systems, was assessed studying the electrochemical properties of these iron-sulfur proteins Adx WT and mutant forms of adrenodoxins. Adx WT, mutant forms R106D and D109R have redox potentials E1/2 significantly more negative than cytochromes P450 (–579 ± 10 mV, –590 ± 15 mV, and –528 ± 10 mV, respectively). These results suggest that Adx WT and mutant forms may be electron donors in the cytochrome P450 systems.

摘要/ abstract摘要:利用光学生物传感器技术研究了细胞色素CYP11A1 (P450scc)与野生型肾上腺素还毒素(Adx WT)和突变型肾上腺素还毒素R106D和D109R配合物的动力学常数和平衡解离常数,研究了配对蛋白在细胞色素P450系统中功能复合物形成中的作用。野生型肾上腺素(Kd =(1.23±0.09)× 10-6 M)和突变型D109R (Kd =(2.37±0.09)× 10-8 M)与细胞色素P450scc形成复合物。在R106D突变体的情况下,没有检测到复杂的形成。通过研究这些铁硫蛋白Adx WT和肾上腺素突变体的电化学性质,评估了肾上腺素及其突变体在线粒体细胞色素P450系统中作为电子供体参与电子转移过程的可能性。与细胞色素P450相比,突变型R106D和D109R的氧化还原电位e2 /2显著负(分别为-579±10 mV、-590±15 mV和-528±10 mV)。这些结果表明,Adx WT和突变体可能是细胞色素P450系统中的电子供体。
{"title":"Adrenodoxins and Their Role in the Cytochrome P450 Systems","authors":"V. V. Shumyantseva,&nbsp;T. V. Bulko,&nbsp;O. V. Gnedenko,&nbsp;E. O. Yablokov,&nbsp;S. A. Usanov,&nbsp;A. S. Ivanov","doi":"10.1134/S1990750822030106","DOIUrl":"10.1134/S1990750822030106","url":null,"abstract":"<div><div><h3>\u0000 <b>Abstract</b>—</h3><p>The role of partner proteins in the formation of functional complexes in cytochrome P450 systems was investigated by means of the optical biosensor technique, used to determine kinetic constants and equilibrium dissociation constants of complexes of cytochrome CYP11A1 (P450scc) with wild-type adrenodoxin (Adx WT) and mutant forms of adrenodoxin R106D and D109R. Wild-type adrenodoxin (<i>K</i><sub>d</sub> = (1.23 ± 0.09) × 10<sup>–6</sup> M) and mutant D109R (<i>K</i><sub>d</sub> = (2.37 ± 0.09) × 10<sup>–8</sup> M) formed complexes with cytochrome P450scc. In the case of the R106D mutant, no complex formation was detected. The possibility of participation of adrenodoxins and their mutant variants in the process of electron transfer as electron donors in mitochondrial cytochrome P450 systems, was assessed studying the electrochemical properties of these iron-sulfur proteins Adx WT and mutant forms of adrenodoxins. Adx WT, mutant forms R106D and D109R have redox potentials <i>E</i><sub>1/2</sub> significantly more negative than cytochromes P450 (–579 ± 10 mV, –590 ± 15 mV, and –528 ± 10 mV, respectively). These results suggest that Adx WT and mutant forms may be electron donors in the cytochrome P450 systems.</p></div></div>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 3","pages":"238 - 245"},"PeriodicalIF":0.6,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4600451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Analysis of Proteins Associated with 26S and 20S Proteasomes Isolated from Rabbit Brain and Liver 兔脑和肝脏中26S和20S蛋白酶体相关蛋白的比较分析
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-08-15 DOI: 10.1134/S1990750822030040
O. A. Buneeva, A. T. Kopylov, V. G. Zgoda, O. V. Gnedenko, S. A. Kaloshina, M. V. Medvedeva, A. S. Ivanov, A. E. Medvedev

The fractions of 26S and 20S proteasomes have been isolated from the rabbit liver and the brain. According to mass spectrometric (MS) analysis, the 26S proteasome fractions from these organs contained catalytic and regulatory subunits characteristic of the proteasome core and regulatory subunits. The 20S fractions of brain and liver proteasomes contained only catalytic proteasome subunits. In addition to the proteasome subunits, the isolated fractions contained components of the ubiquitin-proteasome system, ubiquitinated proteins, enzymes involved in various metabolic processes, cytoskeletal components, signaling, regulatory, and protective proteins, as well as proteins regulating gene expression, cell division, and differentiation. The abundance of a number of proteasome-associated proteins was comparable or exceeded the abundance of intrinsic proteasome components. About a third of the proteins common to all studied fractions (26S and 20S of brain and liver proteasomes) belong to the group of multifunctional proteins. Selective biosensor validation confirmed the affinity binding of proteins (aldolase, phosphoglycerate kinase) identified during MS analysis to the brain 20S proteasome. Comparison of the subproteomes of the 26S and 20S brain proteasomes showed that removal of components of the regulatory (19S) subparticles caused almost two-fold increase in the total number of individual proteins associated with the core part of the proteasome (20S). In the liver, the number of proteins associated with the core part of the proteasome remained basically unchanged after the removal of the components of the regulatory (19S) subparticles. This indicates that in the brain and, possibly, in other organs, proteins of the regulatory (19S) subunit play an important role in the formation of the proteasome interactome.

从家兔肝脏和脑组织中分离到26S和20S蛋白酶体。质谱分析表明,这些器官的26S蛋白酶体组分含有催化和调节亚基,这些亚基具有蛋白酶体核心和调节亚基的特征。脑和肝蛋白酶体的20S部分仅含有催化蛋白酶体亚基。除了蛋白酶体亚基外,分离的组分还含有泛素-蛋白酶体系统的组分、泛素化蛋白、参与各种代谢过程的酶、细胞骨架组分、信号传导、调节和保护蛋白,以及调节基因表达、细胞分裂和分化的蛋白。许多蛋白酶体相关蛋白的丰度与内在蛋白酶体成分的丰度相当或超过。所研究的所有部分(脑和肝蛋白酶体的26S和20S)共有的蛋白质中约有三分之一属于多功能蛋白质组。选择性生物传感器验证证实了在质谱分析中鉴定的蛋白(醛缩酶、磷酸甘油酸激酶)与脑20S蛋白酶体的亲和力结合。对26S和20S脑蛋白酶体亚蛋白质组的比较表明,去除调节(19S)亚颗粒的成分导致与蛋白酶体核心部分(20S)相关的单个蛋白质总数增加了近两倍。在肝脏中,去除调节(19S)亚颗粒的成分后,与蛋白酶体核心部分相关的蛋白质数量基本保持不变。这表明,在大脑中,也可能在其他器官中,调节(19S)亚基的蛋白质在蛋白酶体相互作用组的形成中起着重要作用。
{"title":"Comparative Analysis of Proteins Associated with 26S and 20S Proteasomes Isolated from Rabbit Brain and Liver","authors":"O. A. Buneeva,&nbsp;A. T. Kopylov,&nbsp;V. G. Zgoda,&nbsp;O. V. Gnedenko,&nbsp;S. A. Kaloshina,&nbsp;M. V. Medvedeva,&nbsp;A. S. Ivanov,&nbsp;A. E. Medvedev","doi":"10.1134/S1990750822030040","DOIUrl":"10.1134/S1990750822030040","url":null,"abstract":"<p>The fractions of 26S and 20S proteasomes have been isolated from the rabbit liver and the brain. According to mass spectrometric (MS) analysis, the 26S proteasome fractions from these organs contained catalytic and regulatory subunits characteristic of the proteasome core and regulatory subunits. The 20S fractions of brain and liver proteasomes contained only catalytic proteasome subunits. In addition to the proteasome subunits, the isolated fractions contained components of the ubiquitin-proteasome system, ubiquitinated proteins, enzymes involved in various metabolic processes, cytoskeletal components, signaling, regulatory, and protective proteins, as well as proteins regulating gene expression, cell division, and differentiation. The abundance of a number of proteasome-associated proteins was comparable or exceeded the abundance of intrinsic proteasome components. About a third of the proteins common to all studied fractions (26S and 20S of brain and liver proteasomes) belong to the group of multifunctional proteins. Selective biosensor validation confirmed the affinity binding of proteins (aldolase, phosphoglycerate kinase) identified during MS analysis to the brain 20S proteasome. Comparison of the subproteomes of the 26S and 20S brain proteasomes showed that removal of components of the regulatory (19S) subparticles caused almost two-fold increase in the total number of individual proteins associated with the core part of the proteasome (20S). In the liver, the number of proteins associated with the core part of the proteasome remained basically unchanged after the removal of the components of the regulatory (19S) subparticles. This indicates that in the brain and, possibly, in other organs, proteins of the regulatory (19S) subunit play an important role in the formation of the proteasome interactome.</p>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 3","pages":"195 - 209"},"PeriodicalIF":0.6,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4600464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Lipidomic Markers of Tumor Progress in Breast Cancer Patients 乳腺癌患者肿瘤进展的脂质组学标志物
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-08-15 DOI: 10.1134/S1990750822030118
A. O. Tokareva, N. L. Starodubtseva, V. V. Chagovets, V. V. Rodionov, V. V. Kometova, K. S. Chingin, V. E. Frankevich

Abstract

Research of cancer progression mechanisms and their impact on metabolism of tumor cells and tumor microenvironment cells is an important element in drug development for cancer target therapy. In this study, changes in tumor tissue and margin tissue lipid profiles were investigated for their association with the following clinical and morphological characteristics: tumor size, cancer stage, multifocality, tumor grade, number of lymph node metastases, Nottingham prognostic index, total malignancy score, and the level of Ki67 protein. Lipid profiling was performed by reverse-phase chromato-mass spectrometry analysis of the lipid tissue extract with lipid identification by characteristic fragments. In the lipid profile of tumor tissue 13 characteristic lipids were selected. Their levels significantly correlated with at least 5 clinical and morphological features. Eight of 13 lipid features belonged to phosphatidylcholines. In the lipid profile of tumor microenvironment tissue, 13 lipid features were selected. Their levels significantly correlated with at least 5 clinical and morphological features. Four of 13 lipid features belonged to oxidized lipids, 4 lipid features belonged to sphingomyelins, 4 lipid features belonged to phosphatidylethanolamines. The tumor microenvironment tissue lipid profile correlated with the tumor size, the cancer stage, the tumor grade, the number of axillary metastases, and the Nottingham prognostic index. The tumor tissue lipid profile correlated with tumor size, tumor grade, total malignant score, and number of axillary metastases.

摘要研究肿瘤进展机制及其对肿瘤细胞和肿瘤微环境细胞代谢的影响是肿瘤靶向治疗药物开发的重要内容。在本研究中,我们研究了肿瘤组织和边缘组织脂质谱的变化与以下临床和形态学特征的关系:肿瘤大小、肿瘤分期、多灶性、肿瘤分级、淋巴结转移数量、诺丁汉预后指数、恶性肿瘤总评分和Ki67蛋白水平。脂质分析采用反相质谱法对脂质组织提取物进行分析,并通过特征片段进行脂质鉴定。在肿瘤组织脂质谱中选取了13种特征脂质。它们的水平与至少5个临床和形态学特征显著相关。13个脂质特征中有8个属于磷脂酰胆碱。在肿瘤微环境组织的脂质谱中,选取了13个脂质特征。它们的水平与至少5个临床和形态学特征显著相关。13个脂质特征中有4个属于氧化脂质,4个属于鞘磷脂,4个属于磷脂酰乙醇胺。肿瘤微环境组织脂质谱与肿瘤大小、肿瘤分期、肿瘤分级、腋窝转移数、诺丁汉预后指数相关。肿瘤组织脂质谱与肿瘤大小、肿瘤分级、总恶性评分和腋窝转移数相关。
{"title":"Lipidomic Markers of Tumor Progress in Breast Cancer Patients","authors":"A. O. Tokareva,&nbsp;N. L. Starodubtseva,&nbsp;V. V. Chagovets,&nbsp;V. V. Rodionov,&nbsp;V. V. Kometova,&nbsp;K. S. Chingin,&nbsp;V. E. Frankevich","doi":"10.1134/S1990750822030118","DOIUrl":"10.1134/S1990750822030118","url":null,"abstract":"<div><div><h3>\u0000 <b>Abstract</b>—</h3><p>Research of cancer progression mechanisms and their impact on metabolism of tumor cells and tumor microenvironment cells is an important element in drug development for cancer target therapy. In this study, changes in tumor tissue and margin tissue lipid profiles were investigated for their association with the following clinical and morphological characteristics: tumor size, cancer stage, multifocality, tumor grade, number of lymph node metastases, Nottingham prognostic index, total malignancy score, and the level of Ki67 protein. Lipid profiling was performed by reverse-phase chromato-mass spectrometry analysis of the lipid tissue extract with lipid identification by characteristic fragments. In the lipid profile of tumor tissue 13 characteristic lipids were selected. Their levels significantly correlated with at least 5 clinical and morphological features. Eight of 13 lipid features belonged to phosphatidylcholines. In the lipid profile of tumor microenvironment tissue, 13 lipid features were selected. Their levels significantly correlated with at least 5 clinical and morphological features. Four of 13 lipid features belonged to oxidized lipids, 4 lipid features belonged to sphingomyelins, 4 lipid features belonged to phosphatidylethanolamines. The tumor microenvironment tissue lipid profile correlated with the tumor size, the cancer stage, the tumor grade, the number of axillary metastases, and the Nottingham prognostic index. The tumor tissue lipid profile correlated with tumor size, tumor grade, total malignant score, and number of axillary metastases.</p></div></div>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 3","pages":"253 - 263"},"PeriodicalIF":0.6,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4599412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Population Rearrangement of B Lymphocytes Expressing Chemokine Receptors in Patients with Chronic Obstructive Pulmonary Disease 慢性阻塞性肺疾病患者表达趋化因子受体的B淋巴细胞群体重排
IF 0.6 Q4 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-08-15 DOI: 10.1134/S1990750822030064
A. G. Kadushkin, A. D. Tahanovich, L. V. Movchan, M. M. Zafranskaya, V. V. Dziadzichkina, T. V. Shman

Abstract

To date, there are no drugs that can prevent progressive destruction of lung tissue and small airway fibrosis in patients with chronic obstructive pulmonary disease (COPD). Therefore, molecular mechanisms of this disease are being studied. The aim of this study was to determine the chemokine receptor expression pattern of B lymphocytes from peripheral blood and airways of COPD patients. Peripheral blood was collected from 51 smokers with COPD, 21 healthy smokers, and 20 healthy non-smokers. Seven smokers with COPD and 7 healthy smokers were recruited to undergo bronchoscopy with bronchoalveolar lavage (BAL). The expression of chemokine receptors CCR5, CCR6, CCR7, CXCR3, CXCR4, and CXCR5 on the surface of blood and BAL B lymphocytes was determined by flow cytometry. It was found that the percentage of blood B lymphocytes expressing chemokine receptors CCR5 and CXCR3 was higher in smokers with COPD compared with healthy smokers and healthy non-smokers. The percentage of CD27+ B cells expressing receptors CCR5 and CXCR3 exceeded the proportion of CD27 B lymphocytes expressing these receptors in peripheral blood of patients with COPD and healthy controls. In smoking patients with COPD, the percentage of BAL B cells expressing receptors CCR5 and CXCR3 was also increased compared with healthy smokers. There were no differences in the percentage of B lymphocytes expressing receptors CXCR4, CXCR5, CCR6, and CCR7 in both peripheral blood and BAL between smokers with COPD and healthy smokers. A greater percentage of CD27 B lymphocytes than CD27+ B cells expressed receptors CXCR4, CXCR5, CCR6, and CCR7 in peripheral blood of smokers with COPD and healthy controls. The results of this study indicate a modification in the chemokine receptor profile of B lymphocytes in COPD.

迄今为止,还没有药物可以预防慢性阻塞性肺疾病(COPD)患者肺组织的进行性破坏和小气道纤维化。因此,该疾病的分子机制正在研究中。本研究的目的是测定COPD患者外周血和气道B淋巴细胞趋化因子受体的表达模式。采集了51例COPD吸烟者、21例健康吸烟者和20例健康非吸烟者的外周血。7名慢性阻塞性肺病吸烟者和7名健康吸烟者接受支气管镜检查和支气管肺泡灌洗(BAL)。流式细胞术检测趋化因子受体CCR5、CCR6、CCR7、CXCR3、CXCR4、CXCR5在血液和BAL B淋巴细胞表面的表达。结果发现,COPD吸烟者血液中表达趋化因子受体CCR5和CXCR3的B淋巴细胞比例高于健康吸烟者和健康非吸烟者。COPD患者和健康对照组外周血中表达受体CCR5和CXCR3的CD27+ B细胞的比例超过表达这些受体的CD27 - B淋巴细胞的比例。在吸烟的COPD患者中,与健康吸烟者相比,表达受体CCR5和CXCR3的BAL B细胞百分比也有所增加。慢性阻塞性肺病吸烟者与健康吸烟者外周血和BAL中表达受体CXCR4、CXCR5、CCR6和CCR7的B淋巴细胞百分比无差异。COPD患者和健康对照者外周血中CD27 - B淋巴细胞表达受体CXCR4、CXCR5、CCR6和CCR7的比例高于CD27+ B细胞。本研究结果表明慢性阻塞性肺病患者B淋巴细胞趋化因子受体谱发生改变。
{"title":"Population Rearrangement of B Lymphocytes Expressing Chemokine Receptors in Patients with Chronic Obstructive Pulmonary Disease","authors":"A. G. Kadushkin,&nbsp;A. D. Tahanovich,&nbsp;L. V. Movchan,&nbsp;M. M. Zafranskaya,&nbsp;V. V. Dziadzichkina,&nbsp;T. V. Shman","doi":"10.1134/S1990750822030064","DOIUrl":"10.1134/S1990750822030064","url":null,"abstract":"<div><div><h3>\u0000 <b>Abstract</b>—</h3><p>To date, there are no drugs that can prevent progressive destruction of lung tissue and small airway fibrosis in patients with chronic obstructive pulmonary disease (COPD). Therefore, molecular mechanisms of this disease are being studied. The aim of this study was to determine the chemokine receptor expression pattern of B lymphocytes from peripheral blood and airways of COPD patients. Peripheral blood was collected from 51 smokers with COPD, 21 healthy smokers, and 20 healthy non-smokers. Seven smokers with COPD and 7 healthy smokers were recruited to undergo bronchoscopy with bronchoalveolar lavage (BAL). The expression of chemokine receptors CCR5, CCR6, CCR7, CXCR3, CXCR4, and CXCR5 on the surface of blood and BAL B lymphocytes was determined by flow cytometry. It was found that the percentage of blood B lymphocytes expressing chemokine receptors CCR5 and CXCR3 was higher in smokers with COPD compared with healthy smokers and healthy non-smokers. The percentage of CD27<sup>+</sup> B cells expressing receptors CCR5 and CXCR3 exceeded the proportion of CD27<sup>–</sup> B lymphocytes expressing these receptors in peripheral blood of patients with COPD and healthy controls. In smoking patients with COPD, the percentage of BAL B cells expressing receptors CCR5 and CXCR3 was also increased compared with healthy smokers. There were no differences in the percentage of B lymphocytes expressing receptors CXCR4, CXCR5, CCR6, and CCR7 in both peripheral blood and BAL between smokers with COPD and healthy smokers. A greater percentage of CD27<sup>–</sup> B lymphocytes than CD27<sup>+</sup> B cells expressed receptors CXCR4, CXCR5, CCR6, and CCR7 in peripheral blood of smokers with COPD and healthy controls. The results of this study indicate a modification in the chemokine receptor profile of B lymphocytes in COPD.</p></div></div>","PeriodicalId":485,"journal":{"name":"Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry","volume":"16 3","pages":"216 - 224"},"PeriodicalIF":0.6,"publicationDate":"2022-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"4599711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1